Logo image of EXO.AS

EXOR NV (EXO.AS) Stock Fundamental Analysis

AMS:EXO - Euronext Amsterdam - NL0012059018 - Common Stock - Currency: EUR

92.65  -0.75 (-0.8%)

Fundamental Rating

6

EXO gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 50 industry peers in the Financial Services industry. EXO scores excellent points on both the profitability and health parts. This is a solid base for a good stock. EXO has a bad growth rate and is valued cheaply. These ratings would make EXO suitable for value investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

EXO had positive earnings in the past year.
EXO had a positive operating cash flow in the past year.
Of the past 5 years EXO 4 years were profitable.
EXO had a positive operating cash flow in each of the past 5 years.
EXO.AS Yearly Net Income VS EBIT VS OCF VS FCFEXO.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5B 10B

1.2 Ratios

EXO has a better Return On Assets (38.83%) than 100.00% of its industry peers.
EXO's Return On Equity of 43.64% is amongst the best of the industry. EXO outperforms 92.00% of its industry peers.
The Return On Invested Capital of EXO (5.50%) is better than 66.00% of its industry peers.
EXO had an Average Return On Invested Capital over the past 3 years of 6.24%. This is below the industry average of 11.19%.
Industry RankSector Rank
ROA 38.83%
ROE 43.64%
ROIC 5.5%
ROA(3y)3.79%
ROA(5y)2.62%
ROE(3y)16.25%
ROE(5y)13.77%
ROIC(3y)6.24%
ROIC(5y)5.46%
EXO.AS Yearly ROA, ROE, ROICEXO.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 10 15 20

1.3 Margins

EXO's Profit Margin of 71.58% is amongst the best of the industry. EXO outperforms 96.00% of its industry peers.
In the last couple of years the Profit Margin of EXO has grown nicely.
EXO's Operating Margin of 11.86% is in line compared to the rest of the industry. EXO outperforms 58.00% of its industry peers.
EXO's Operating Margin has improved in the last couple of years.
EXO has a Gross Margin (53.35%) which is in line with its industry peers.
EXO's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 11.86%
PM (TTM) 71.58%
GM 53.35%
OM growth 3Y19.02%
OM growth 5Y18.67%
PM growth 3YN/A
PM growth 5Y58.4%
GM growth 3Y6.24%
GM growth 5Y12.17%
EXO.AS Yearly Profit, Operating, Gross MarginsEXO.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 10 15 20 25

More info and screens

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), EXO is destroying value.
The number of shares outstanding for EXO has been reduced compared to 1 year ago.
The number of shares outstanding for EXO has been reduced compared to 5 years ago.
EXO has a worse debt/assets ratio than last year.
EXO.AS Yearly Shares OutstandingEXO.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
EXO.AS Yearly Total Debt VS Total AssetsEXO.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50B 100B 150B

2.2 Solvency

EXO has an Altman-Z score of 4.60. This indicates that EXO is financially healthy and has little risk of bankruptcy at the moment.
EXO has a better Altman-Z score (4.60) than 78.00% of its industry peers.
EXO has a debt to FCF ratio of 1.26. This is a very positive value and a sign of high solvency as it would only need 1.26 years to pay back of all of its debts.
The Debt to FCF ratio of EXO (1.26) is better than 82.00% of its industry peers.
EXO has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.09, EXO is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 1.26
Altman-Z 4.6
ROIC/WACC0.78
WACC7.03%
EXO.AS Yearly LT Debt VS Equity VS FCFEXO.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B 40B 50B

2.3 Liquidity

EXO has a Current Ratio of 1.21. This is a normal value and indicates that EXO is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.21, EXO perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
A Quick Ratio of 1.21 indicates that EXO should not have too much problems paying its short term obligations.
EXO has a better Quick ratio (1.21) than 62.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 1.21
EXO.AS Yearly Current Assets VS Current LiabilitesEXO.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20B 40B 60B 80B

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 178.59% over the past year.
The Earnings Per Share has been growing by 26.35% on average over the past years. This is a very strong growth
The Revenue for EXO has decreased by -47.50% in the past year. This is quite bad
Measured over the past years, EXO shows a very negative growth in Revenue. The Revenue has been decreasing by -20.77% on average per year.
EPS 1Y (TTM)178.59%
EPS 3YN/A
EPS 5Y26.35%
EPS Q2Q%598.56%
Revenue 1Y (TTM)-47.5%
Revenue growth 3Y18.64%
Revenue growth 5Y-20.77%
Sales Q2Q%-100%

3.2 Future

The Earnings Per Share is expected to decrease by -12.70% on average over the next years. This is quite bad
EXO is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -4.06% yearly.
EPS Next Y-43.57%
EPS Next 2Y-22.72%
EPS Next 3Y-12.7%
EPS Next 5YN/A
Revenue Next Year-13.72%
Revenue Next 2Y-4.06%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EXO.AS Yearly Revenue VS EstimatesEXO.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50B 100B 150B
EXO.AS Yearly EPS VS EstimatesEXO.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5 10 15

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 1.22, the valuation of EXO can be described as very cheap.
96.00% of the companies in the same industry are more expensive than EXO, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of EXO to the average of the S&P500 Index (29.35), we can say EXO is valued rather cheaply.
EXO is valuated reasonably with a Price/Forward Earnings ratio of 10.31.
EXO's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. EXO is cheaper than 70.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.10, EXO is valued rather cheaply.
Industry RankSector Rank
PE 1.22
Fwd PE 10.31
EXO.AS Price Earnings VS Forward Price EarningsEXO.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

EXO's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. EXO is cheaper than 78.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, EXO is valued cheaply inside the industry as 86.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.24
EV/EBITDA 6.16
EXO.AS Per share dataEXO.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

The decent profitability rating of EXO may justify a higher PE ratio.
EXO's earnings are expected to decrease with -12.70% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.05
EPS Next 2Y-22.72%
EPS Next 3Y-12.7%

More info and screens

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.49%, EXO is not a good candidate for dividend investing.
EXO's Dividend Yield is comparable with the industry average which is at 3.76.
Compared to an average S&P500 Dividend Yield of 2.33, EXO's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.49%

5.2 History

The dividend of EXO is nicely growing with an annual growth rate of 21.92%!
Dividend Growth(5Y)21.92%
Div Incr Years1
Div Non Decr Years1
EXO.AS Yearly Dividends per shareEXO.AS Yearly Dividends per shareYearly Dividends per share 2023 2024 0.1 0.2 0.3 0.4

5.3 Sustainability

EXO pays out 0.75% of its income as dividend. This is a sustainable payout ratio.
DP0.75%
EPS Next 2Y-22.72%
EPS Next 3Y-12.7%
EXO.AS Yearly Income VS Free CF VS DividendEXO.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B 4B 5B
EXO.AS Dividend Payout.EXO.AS Dividend Payout, showing the Payout Ratio.EXO.AS Dividend Payout.PayoutRetained Earnings

More info and screens

EXOR NV

AMS:EXO (3/7/2025, 7:00:00 PM)

92.65

-0.75 (-0.8%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)09-24 2024-09-24
Earnings (Next)03-26 2025-03-26/amc
Inst Owners27.54%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap20.47B
Analysts83.33
Price Target124.57 (34.45%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.49%
Yearly Dividend3.23
Dividend Growth(5Y)21.92%
DP0.75%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.19%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-78.94%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 1.22
Fwd PE 10.31
P/S 0.88
P/FCF 6.24
P/OCF 4.04
P/B 0.53
P/tB 0.53
EV/EBITDA 6.16
EPS(TTM)75.83
EY81.85%
EPS(NY)8.99
Fwd EY9.7%
FCF(TTM)14.85
FCFY16.03%
OCF(TTM)22.94
OCFY24.76%
SpS105.78
BVpS173.51
TBVpS173.51
PEG (NY)N/A
PEG (5Y)0.05
Profitability
Industry RankSector Rank
ROA 38.83%
ROE 43.64%
ROCE 6.54%
ROIC 5.5%
ROICexc 5.6%
ROICexgc 5.6%
OM 11.86%
PM (TTM) 71.58%
GM 53.35%
FCFM 14.04%
ROA(3y)3.79%
ROA(5y)2.62%
ROE(3y)16.25%
ROE(5y)13.77%
ROIC(3y)6.24%
ROIC(5y)5.46%
ROICexc(3y)7.53%
ROICexc(5y)7.01%
ROICexgc(3y)9.25%
ROICexgc(5y)9.93%
ROCE(3y)7.42%
ROCE(5y)6.5%
ROICexcg growth 3Y29.17%
ROICexcg growth 5Y-3.84%
ROICexc growth 3Y51.05%
ROICexc growth 5Y2.28%
OM growth 3Y19.02%
OM growth 5Y18.67%
PM growth 3YN/A
PM growth 5Y58.4%
GM growth 3Y6.24%
GM growth 5Y12.17%
F-Score7
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 1.26
Debt/EBITDA 0.9
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 131.15%
Profit Quality 19.62%
Current Ratio 1.21
Quick Ratio 1.21
Altman-Z 4.6
F-Score7
WACC7.03%
ROIC/WACC0.78
Cap/Depr(3y)127.54%
Cap/Depr(5y)135.28%
Cap/Sales(3y)5.99%
Cap/Sales(5y)12.68%
Profit Quality(3y)78.49%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)178.59%
EPS 3YN/A
EPS 5Y26.35%
EPS Q2Q%598.56%
EPS Next Y-43.57%
EPS Next 2Y-22.72%
EPS Next 3Y-12.7%
EPS Next 5YN/A
Revenue 1Y (TTM)-47.5%
Revenue growth 3Y18.64%
Revenue growth 5Y-20.77%
Sales Q2Q%-100%
Revenue Next Year-13.72%
Revenue Next 2Y-4.06%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-51.53%
EBIT growth 3Y41.21%
EBIT growth 5Y-5.98%
EBIT Next Year-57.01%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-86.43%
FCF growth 3Y-3.28%
FCF growth 5Y-7.35%
OCF growth 1Y-80.71%
OCF growth 3Y-23.68%
OCF growth 5Y-12.53%